|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/12 | (2006.01) |
| C07D 405/12 | (2013.01) | ||
| C08G 65/331 | (2006.01) | ||
| A61K 38/07 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61K 38/07 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 47/10 | (2017.01) | ||
| C07K 5/10 | (2006.01) | ||
| C07K 5/117 | (2006.01) |
| (11) | Number of the document | 3464277 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17730293.2 |
| Date of filing the European patent application | 2017-05-23 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/034029 |
| Date | 2017-05-23 |
| (87) | Number | WO 2017/205392 |
| Date | 2017-11-30 |
| (30) | Number | Date | Country code |
| 201662340926 P | 2016-05-24 | US | |
| 201762485812 P | 2017-04-14 | US |
| (72) |
LUEHR, Gary , US
ANIK, Shabbir T. , US
PENG, Ge , US
DOTSENKO, Irina , US
PHIASIVONGSA, Pasit , US
ROMANINI, Dante , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320,
US
|
| (54) | PEGYLATED CARFILZOMIB COMPOUNDS |
| PEGYLATED CARFILZOMIB COMPOUNDS |